Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Credit Rating
The Company has received the ratings outstanding for debt instruments/facilities for the Company by CRISIL Ratings Limited (CRISIL)02-01-2024
02-01-2024
Advanced Enzyme Technologies Ltd - 540025 - Intimation Under Regulation 30 Read With Schedule III Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
In terms of Regulation 30 and Schedule III to the Securities and Exchange Board of India ( Listing Obligation and Disclosure Requirements) Regulation, 2015 (as, amended) , the requisite details of Order received by the Company from The Goods & Service Tax(GST) Authority is enclosed.28-12-2023
Advanced Enzyme Technologies Ltd - 540025 - Closure of Trading Window
The "Trading Window " for the trading in the securities of the company, shall remain closed from January 01, 2024 (Monday) till 48 hours after the announcement of companies financial results for the quarter and nine months ended December 31, 202328-12-2023
Advanced Enzyme Technologies Ltd - 540025 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Advanced Vital Enzymes Pvt Ltd20-12-2023
Advanced Enzyme Technologies Ltd - 540025 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Advanced Vital Enzymes Pvt Ltd20-12-2023
Advanced Enzyme Technologies Ltd - 540025 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Advanced Vital Enzymes Pvt Ltd18-12-2023
Advanced Enzyme Technologies Ltd - 540025 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Advanced Vital Enzymes Pvt Ltd15-12-2023
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Advanced Enzyme Technologies Limited has informed the Exchange about Schedule of meet - Value Quest15-12-2023
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Advanced Enzyme Technologies Limited has informed the Exchange about Schedule of meet - Ashika India Alpha Fund15-12-2023
Advanced Enzyme Technologies Ltd - 540025 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Advanced Vital Enzymes Pvt Ltd15-12-2023